JP2004538320A5 - - Google Patents

Download PDF

Info

Publication number
JP2004538320A5
JP2004538320A5 JP2003518575A JP2003518575A JP2004538320A5 JP 2004538320 A5 JP2004538320 A5 JP 2004538320A5 JP 2003518575 A JP2003518575 A JP 2003518575A JP 2003518575 A JP2003518575 A JP 2003518575A JP 2004538320 A5 JP2004538320 A5 JP 2004538320A5
Authority
JP
Japan
Prior art keywords
gly
asp
thrombin peptide
amino acids
peptide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003518575A
Other languages
English (en)
Japanese (ja)
Other versions
JP4192093B2 (ja
JP2004538320A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/001151 external-priority patent/WO2003013569A2/en
Publication of JP2004538320A publication Critical patent/JP2004538320A/ja
Publication of JP2004538320A5 publication Critical patent/JP2004538320A5/ja
Application granted granted Critical
Publication of JP4192093B2 publication Critical patent/JP4192093B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003518575A 2001-07-27 2002-01-16 慢性皮膚潰瘍の治癒を促進する方法 Expired - Fee Related JP4192093B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30819801P 2001-07-27 2001-07-27
PCT/US2002/001151 WO2003013569A2 (en) 2001-07-27 2002-01-16 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Publications (3)

Publication Number Publication Date
JP2004538320A JP2004538320A (ja) 2004-12-24
JP2004538320A5 true JP2004538320A5 (enExample) 2006-01-05
JP4192093B2 JP4192093B2 (ja) 2008-12-03

Family

ID=23192964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003518575A Expired - Fee Related JP4192093B2 (ja) 2001-07-27 2002-01-16 慢性皮膚潰瘍の治癒を促進する方法

Country Status (11)

Country Link
US (3) US7049294B2 (enExample)
EP (1) EP1414487B1 (enExample)
JP (1) JP4192093B2 (enExample)
CN (1) CN100509055C (enExample)
AT (1) ATE328606T1 (enExample)
AU (1) AU2002236768B2 (enExample)
CA (1) CA2455756C (enExample)
DE (1) DE60212143T2 (enExample)
DK (1) DK1414487T3 (enExample)
ES (1) ES2271216T3 (enExample)
WO (1) WO2003013569A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100509055C (zh) * 2001-07-27 2009-07-08 奥索洛吉艾斯有限公司 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡
CA2491135A1 (en) * 2002-07-02 2004-01-15 The Board Of Regents, The University Of Texas System Thrombin peptide derivative dimers
EP1539214A4 (en) * 2002-07-02 2008-01-02 Orthologic Corp Thrombin
DK1559431T3 (da) 2003-12-31 2007-07-30 Orthologic Corp Farmaceutisk sammensætning til thrombinpeptidderivater
WO2007035406A1 (en) * 2005-09-16 2007-03-29 Orthologic Corp. Antibodies to complementary peptides of thrombin or portions thereof
WO2008124172A1 (en) * 2007-04-10 2008-10-16 The Board Of Regents, The University Of Texas System Combination therapy for chronic dermal ulcers
JP2011515471A (ja) * 2008-03-26 2011-05-19 オーソロジック コーポレイション 急性心筋梗塞を処置するための方法
CA2722620A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
WO2009120304A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
US8952129B2 (en) * 2008-03-26 2015-02-10 The Board Of Regents Of The University Of Texas System Method of treating degenerative diseases
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
BR112012018570A2 (pt) * 2010-02-24 2019-09-24 Syneron Medical Ltd aparelho modelador de corpo
US8806615B2 (en) 2010-11-04 2014-08-12 Mcafee, Inc. System and method for protecting specified data combinations
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
KR100946980B1 (ko) * 2000-12-01 2010-03-17 리스판스 지네틱스, 인크. 표피 성장 인자 수용체 및 her2-neu 유전자 발현 및 이들 수준과 생존율의 상관성을 측정하는 방법
CN100509055C (zh) * 2001-07-27 2009-07-08 奥索洛吉艾斯有限公司 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡

Similar Documents

Publication Publication Date Title
Zhang et al. Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in silico and in vitro analyses
EP0665754B1 (en) Antimicrobial peptides
Deddish et al. Naturally occurring active N-domain of human angiotensin I-converting enzyme.
AU2013347975B2 (en) Improved peptide pharmaceuticals for insulin resistance
AU2012255119B2 (en) Improved peptide pharmaceuticals for insulin resistance
AU2012255116B2 (en) Improved peptide pharmaceuticals
JP2010522540A5 (enExample)
RU2000109305A (ru) ЗАЖИВЛЕНИЕ ПЕРЕЛОМОВ С ПОМОЩЬЮ АНАЛОГОВ ПЕПТИДА, ПОДОБНОГО ПАРАТИРЕОИДНОМУ ГОРМОНУ (РТНrР)
JP2008511323A5 (enExample)
CA2302255A1 (en) Fracture healing using pthrp analogs
WO2011036443A2 (en) Polypeptides and uses thereof
JP2002509854A5 (enExample)
JP2015504052A5 (enExample)
JP2019533722A5 (enExample)
CN100509055C (zh) 使用凝血酶衍生的缩氨酸治疗慢性真皮溃疡
WO2004009625A3 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES
RU2014134287A (ru) Бифункциональный пептид
WO2004014937A3 (en) Thrombin peptide derivatives
US12214024B2 (en) Use of APC analogue for wound healing
US11555055B2 (en) Peptide inhibitors of insulin-degrading enzyme
JPH05502046A (ja) フィブロネクチン結合タンパク質
CN101657465B (zh) 肽、组合物及其应用
JP2011515471A5 (enExample)
CN105025920A (zh) 具有因子Xa衍生物的组织因子途径抑制剂的抑制
MXPA04007170A (es) Peptidos sinteticos y usos de los mismos para la prevencion y la terapia de metastasis e invasion de cancer.